MOMCare: Culturally Relevant Treatment Services for Perinatal Depression
| Status: | Completed |
|---|---|
| Conditions: | Depression, Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2010 |
| End Date: | August 2014 |
For Moms: Culturally Relevant Treatment Services for Perinatal Depression
The study will evaluate the effectiveness of a culturally relevant, multi-component
intervention for antenatal depression. The intervention includes an engagement session, and
the woman's choice of brief interpersonal psychotherapy and/or pharmacotherapy in a stepped
care treatment for depression model.
intervention for antenatal depression. The intervention includes an engagement session, and
the woman's choice of brief interpersonal psychotherapy and/or pharmacotherapy in a stepped
care treatment for depression model.
The randomized control trial will evaluate the effects of a culturally relevant,
multi-component intervention for antenatal depression. MOMCare has the potential to overcome
patient, provider, and system-level barriers to care and engage depressed, low-income women
in evidence-based treatments to reduce antenatal depressive symptoms, improve maternal
psychosocial functioning, and ameliorate postpartum depression. Specific Aim 1: To evaluate
the impact of MOMCare on treatment engagement and retention. Specific Aim 2: To evaluate the
impact of MOMCare on maternal clinical symptoms and functional outcomes. Specific Aim 3: To
conduct an incremental cost-effectiveness analysis for a health care and welfare agency
perspective that includes a) tracking the medical costs of health service use in MOMCare and
usual care patients; b) monitoring the use of infant preventative health services in both
groups; and c) tracking the percentage of women on Medicaid and the percentage working in
both groups.
The intervention will be assessed through a practical randomized controlled trial in which
we have recruited 168 pregnant women with major depression and/or dysthymia who were on
Medicaid and/or received Maternal Support Services (MSS) in selected public health centers
in Seattle - King County (PHSKC). Patients who were eligible and consented to study
enrollment were randomly assigned to either usual care (UC) or MOMCare. Baseline and four
follow-up assessments (3 - 18 months post-baseline) are scheduled for study participants in
both groups. The MOMCare intervention includes a choice of brief interpersonal psychotherapy
or collaborative management of antidepressant medication. Treatment response will be
monitored, and the treatment will be adjusted as necessary (adding treatments, increasing
dosages).
multi-component intervention for antenatal depression. MOMCare has the potential to overcome
patient, provider, and system-level barriers to care and engage depressed, low-income women
in evidence-based treatments to reduce antenatal depressive symptoms, improve maternal
psychosocial functioning, and ameliorate postpartum depression. Specific Aim 1: To evaluate
the impact of MOMCare on treatment engagement and retention. Specific Aim 2: To evaluate the
impact of MOMCare on maternal clinical symptoms and functional outcomes. Specific Aim 3: To
conduct an incremental cost-effectiveness analysis for a health care and welfare agency
perspective that includes a) tracking the medical costs of health service use in MOMCare and
usual care patients; b) monitoring the use of infant preventative health services in both
groups; and c) tracking the percentage of women on Medicaid and the percentage working in
both groups.
The intervention will be assessed through a practical randomized controlled trial in which
we have recruited 168 pregnant women with major depression and/or dysthymia who were on
Medicaid and/or received Maternal Support Services (MSS) in selected public health centers
in Seattle - King County (PHSKC). Patients who were eligible and consented to study
enrollment were randomly assigned to either usual care (UC) or MOMCare. Baseline and four
follow-up assessments (3 - 18 months post-baseline) are scheduled for study participants in
both groups. The MOMCare intervention includes a choice of brief interpersonal psychotherapy
or collaborative management of antidepressant medication. Treatment response will be
monitored, and the treatment will be adjusted as necessary (adding treatments, increasing
dosages).
Inclusion Criteria:
- 18 or older
- pregnant: 12-32 weeks gestation
- able to speak English
- telephone access
- major depressive disorder or dysthymia
- on Medicaid
- receiving health care in King County, Washington
Exclusion Criteria:
- currently in psychotherapy
- currently receiving pharmacotherapy from a psychiatrist
- high suicide risk
- history of bipolar disorder
- history of schizophrenia
- substance use or dependence in previous 3 months
- currently in a relationship with severe interpersonal violence
- history of repetitive self-harm behavior
We found this trial at
1
site
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
Click here to add this to my saved trials
